Agneta Lissmats

In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden

Nicole Blijlevens, Maarten de Chateau, Gergely Kriván et al. · Bone Marrow Transplantation · 2012 · 48 citations

Pharmacy, Pharmacotherapy, Oral Oncology +9

Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic <i>Escherichia coli</i> diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa

Anu Kantele, Marianna Riekkinen, T. Sakari Jokiranta et al. · Journal of Travel Medicine · 2023 · 35 citations · Full text

Medicine, Immunology, Infectious Diseases +17

A simple two‐stage design for quantitative responses with application to a study in diabetic neuropathic pain

John Whitehead, Elsa Valdés‐Márquez, Agneta Lissmats · Pharmaceutical Statistics · 2008 · 22 citations

Medicine, Biostatistics, Oncology +17

Pharmacokinetic and pharmacodynamic interactions between palifermin and heparin

Bingbing Yang, Brad Gillespie, Brian P. Smith et al. · The Journal of Clinical Pharmacology · 2015 · 15 citations

Medicine, Pharmacokinetics, Pharmacology +13

Randomized Controlled Trial of Two Different Dosing Regimens of Palifermin to Prevent Mucositis In Multiple Myeloma Patients Receiving One-Day Administration of High-Dose Melphalan

Nicole M. A. Blijlevens, Maarten E de Chateau, Gergely Kriván et al. · Blood · 2010 · 10 citations

Pharmacy, Pharmacology, Pharmacotherapy +17